Abstract
BackgroundBevacizumab, a monoclonal antibody to the vascular endothelial growth factor Veg F appears to offer successful treatment of severe retinopathy of prematurity (ROP), but there are no human data addressing...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have